3rd quarter 2023
MEETING OF THE SCIENTIFIC ADVISORY BOARD
The Scientific Advisory Board, composed of Prof. Alberto Mantovani – Scientific Director, Humanitas Clinical Institute; Prof. Giorgio Racagni – President Emeritus, Italian Society of Pharmacology; and Dr. Tiziana Redaelli – Emeritus Head, Spinal Unit, Grande Ospedale Metropolitano Niguarda, convened in Milan to discuss strategic aspects related to the scientific development of the Society.
The agenda for the first meeting included the following presentations:
Our history | Guido Fumagalli, President and Medical Director
Who we are and where we are heading | Cristiana Vignoli, Chief Executive Officer
REMaST ® | Massimo Locati, Scientific Director
Preclinical results | Ilaria Decimo, Research & Development Director
Development of REMaST up to GLP | Francesco Bifari, Therapy Development Director
Clinical studies | Giuseppe Dastoli, Clinical Development Director
Strategic positioning | Gianfranco Bellezza, Scientific Marketing Manager
ENROLMENT OF THE FIRST PATIENT IN THE OBSERVATIONAL STUDY
Within the framework of the prospective observational study initiated at several Centers of Excellence in Northern Italy, the first patient with an acute and complete spinal cord injury was enrolled at the Grande Ospedale Metropolitano Niguarda on July 17. This patient will be monitored for the next 12 months with the aim of collecting data and neurophysiological parameters essential for designing the subsequent interventional-pharmacological study with REMaST® cellular therapy, scheduled to commence in 2025.
Milan’s Niguarda Hospital is a center of excellence for the treatment and rehabilitation of spinal cord injuries. The Spinal Unit, led by Dr. Michele Spinelli, is one of the major Italian hubs for the rehabilitation and care of individuals with traumatic spinal cord pathologies requiring specific rehabilitation programs.
The medical team consists of physiatrists, urologists, neurologists, anesthesiologists, and intensive care specialists, with the collaboration of many other experts.
With 30 beds and approximately 120 annual admissions, the facility serves as a national reference point for individuals with spinal cord injuries, attracting patients from across Italy.